Viral Infections

  • Sawko W. Wassilew


Viral infections involving the skin occur worldwide. Human papilloma (HPV), herpes simplex (HSV), and varizella/zoster (VZV) viruses are widely distributed all over the continents. In hot climate zones, the risk of acquiring viral infections is generally increased due to high population density, light clothing, and inadequate sanitary conditions for both ubiquitous and endemic agents. International travel of businessmen and holidaymakers facilitates the contacts with infected carriers or vectors which transmit viruses, and infections limited to tropical regions are occasionally imported by travelers to Europe, including dengue and chikungunya fever [1]. They often present exanthemas which can be subtle and may occur weeks after infection without any other distinctive clinical sign [2]. In addition, legal or illegal migrants with pigmented or dark skin and common viral skin diseases may enter countries in moderate climate zones.


  1. 1.
    Schwarz TF, Jäger G, Gilch S, et al. Travel-related vector borne virus infections in Germany. Arch Virol Suppl. 1996;11:57–65.PubMedGoogle Scholar
  2. 2.
    Fischer M, Schliemann S. Exanthems and fever in travelers returning from the tropics. Hautarzt. 2014;65:862–72.CrossRefPubMedGoogle Scholar
  3. 3.
    Mays RM, Gordon RA, Javed S, et al. Viral diseases. In: Faber WR, Hay RJ, Naafs B, editors. Imported skin diseases. 2nd ed. Hoboken: Wiley-Blackwell; 2013. p. 123–47. Chapter 12.Google Scholar
  4. 4.
    Carneiro SC, Cestari T, Allen SH, et al. Viral exanthems in the tropics. Clin Dermatol. 2007;25:212–20.CrossRefPubMedGoogle Scholar
  5. 5.
    Friedman DO, Weld LH, Kozarsky PE, et al. Spectrum of diseases and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354:119–30.CrossRefGoogle Scholar
  6. 6.
    Androphy EJ, Kirnbauer R. Human papilloma virus infections. In: Goldsmith LA, Katz SI, Gilchrest BA, et al., editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill; 2012. p. 2421–33. Chapter 196.Google Scholar
  7. 7.
    Bernard HU, Burk RD, Chen Z, et al. Classification of papilloma viruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401:70–9.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Hanson D, Diven DG. Molluscum contagiosum. Dermatol Online J. 2003;9:2–8.PubMedGoogle Scholar
  9. 9.
    Piggott C, Friedlander SF, Tom W. Poxvirus infections. In: Goldsmith LA, Katz SI, Gilchrest BA, et al., editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill; 2012. p. 2402–11. Chapter 195.Google Scholar
  10. 10.
    van der Wouden JC, van des Sande R, van Suijekom-Snit LW, et al. Intervention for cutaneous molluscum contagiosum. Cochrane Database Syst Rev 2009;(4):CD004767.Google Scholar
  11. 11.
    Fathazadeh W, Schwartz RA. Human herpes virus infections: epidemiology, pathogenesis, symptomatic, diagnosis and management. J Am Acad Dermatol. 2007;57:737–63.CrossRefGoogle Scholar
  12. 12.
    Arduino PG, Porter SR. Oral and perioral herpes simplex virus type I infection: review of its management. Oral Dis. 2006;12:254–70.CrossRefPubMedGoogle Scholar
  13. 13.
    Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections. An evidence-based review. Arch Intern Med. 2008;168:1137–44.CrossRefPubMedGoogle Scholar
  14. 14.
    Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365–76.CrossRefPubMedGoogle Scholar
  15. 15.
    Tognoti E. The eradication of smallpox, a success story for modern medicine and public health: what lessons for the future? J Infect Dev Ctries. 2010;4:264–6.Google Scholar
  16. 16.
    Cohen JI. Clinical practice: herpes zoster. N Engl J Med. 2013;369:255–63.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Bader MS. Herpes zoster: diagnostic, therapeutic, and preventive approaches. Postgrad Med. 2013;125:78–91.CrossRefPubMedGoogle Scholar
  18. 18.
    Whitley RJ, Volpi A, McKendrick M, et al. Management of herpes zoster and postherpetic neuralgia now and in the future. J Clin Virol. 2010;48:20–8.CrossRefGoogle Scholar
  19. 19.
    Gross G, Schoefer H, Wassilew S, et al. Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol. 2003;26:277–89.CrossRefPubMedGoogle Scholar
  20. 20.
    Johnson RW, Rice ASC. Postherpetic neuralgia. N Engl J Med. 2014;371:1526–36.CrossRefGoogle Scholar
  21. 21.
    De Araujo T, Berman B, Weinstein A. Human herpes viruses 6 and 7. Dermatol Clin. 2002;20:301–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Amer A, Fischer H, Li X. The natural history of pityriasis rosea in black American children: how correct in the classic description? Arch Pediatr Adolesc Med. 2007;161:503–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Vano-Galvan S, Ma DL, Lopez-Neyra A, et al. Atypical pityriasis rosea in a black child: a case report. Cases J. 2009;2:6796.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Drago F, Ciccarese G, Thanasi H, et al. Facial involvement in pityriasis rosea: differences among Caucasian and dark-skinned patients. G Ital Dermatol Venereol. 2016;151:571–2.PubMedGoogle Scholar
  25. 25.
    Jacyk WK. Pityriasis rosea in Nigerians. Int J Dermatol. 1980;19:397–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Kallini JR, Riaz F, Khachemoune A. Tinea versicolor in dark-skinned individuals. Int J Dermatol. 2014;53:137–41.CrossRefPubMedGoogle Scholar
  27. 27.
    Fortuna C, Remoli ME, Rizzo C, et al. Imported arboviral infections in Italy, July 2014-October 2015: a National Reference Laboratory report. BMC Infect Dis. 2017;17:216.
  28. 28.
    Guzman MG, Kouri G, Bravo J, et al. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002;6:118–24.CrossRefPubMedGoogle Scholar
  29. 29.
    Napoli C, Salcuni P, Pompa MG, et al. Estimated imported infections of chikungunya and dengue in Italy, 2008 to 2011. J Travel Med. 2012;19:294–7.CrossRefPubMedGoogle Scholar
  30. 30.
    McCallum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014;58:260–7.CrossRefGoogle Scholar
  31. 31.
    zur Hausen H. Papilloma viruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–50.CrossRefPubMedGoogle Scholar
  32. 32.
    Ali H, McManus H, O’Connor CC, et al. Human papillomavirus vaccination and genital warts in young indigenous Australians: national sentinel surveillance data. Med J Aust. 2017;206:204–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Venturas C, Umeh K. Health professional feedback on HPV vaccination roll-out in a developing country. Vaccine. 2017;35:1886–91. pii: S0264-410X(17)30265-7.
  34. 34.
    Marin M, Güris D, Chaves SS. Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2007;56:1–50.PubMedGoogle Scholar
  35. 35.
    Oxman MN. Zoster vaccine: current status and future aspects. Clin Infect Dis. 2010;51:197–213.CrossRefPubMedGoogle Scholar
  36. 36.
    Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375:1019–32.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Sawko W. Wassilew
    • 1
  1. 1.Centre of DermatologyKrefeldGermany

Personalised recommendations